ECG Sequence Analysis for Sudden Cardiac Death Risk Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying individuals at risk for sudden cardiac death (SCD) lack sensitivity and specificity, particularly in low and intermediate risk groups, and are unable to accurately predict SCD in patients without severe left ventricular dysfunction or heart failure.
Innovation Solution
A non-invasive method using digital electrocardiogram (ECG) sequences from standard resting ECG machines to identify unique patterns associated with SCD risk, involving preprocessing and optimization techniques to isolate and quantify SCD-specific sequences, allowing for high sensitivity and specificity in risk prediction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods for identifying SCD risk are used, then the screening process is simple and widely applicable, but the sensitivity and specificity are insufficient (less than 90%)
Solution Approach 1:
The patent segments the continuous ECG signal into discrete sequences of specific durations (e.g., 2.5 seconds, 5 seconds, 10 seconds) that can be independently analyzed. This segmentation allows the system to identify specific temporal patterns associated with SCD risk while maintaining computational efficiency and clinical applicability.
Solution Approach 2:
The patent introduces an intermediary processing layer that transforms raw ECG data into standardized sequence formats suitable for pattern recognition algorithms. This intermediary step enables the system to achieve high sensitivity and specificity by preparing the data appropriately for analysis without requiring complex direct processing of raw signals.
2Measurement precision
If comprehensive risk assessment is performed to improve accuracy, then sensitivity and specificity increase, but the time required for assessment increases
Solution Approach 1:
The patent performs preliminary processing of ECG data into standardized sequences during data acquisition, preparing the information in advance for rapid pattern recognition. This preliminary action allows comprehensive analysis without increasing assessment time, as the data is pre-organized into analyzable formats.
Solution Approach 2:
The patent analyzes specific critical sequences of predetermined durations (2.5s, 5s, 10s) rather than processing the entire ECG recording. This partial action approach focuses computational resources on the most diagnostically relevant temporal patterns, achieving high accuracy without requiring analysis of all available data.
3Ease of operation
If standard resting ECG machines are used, then the method is non-invasive and easily accessible, but the ability to detect unique SCD patterns is limited
Solution Approach 1:
The patent replaces complex mechanical or invasive monitoring systems with sophisticated software-based pattern recognition algorithms that analyze standard ECG outputs. This substitution maintains ease of access using conventional equipment while dramatically improving detection capability through computational analysis of temporal patterns.
Solution Approach 2:
The patent changes the analysis parameter from conventional ECG interpretation to temporal sequence pattern recognition. By focusing on specific time-duration patterns (2.5s, 5s, 10s sequences) rather than traditional waveform morphology alone, the system extracts additional diagnostic information from standard ECG machines, enhancing detection precision without requiring new hardware.
Data Source
AI summary
A method and apparatus for the quantitative determination of an individual's risk for sudden cardiac death (SCD) is described. Risk stratification is accomplished (and may have a sensitivity and specificity of greater than about 90%) by determining the presence in any individual being tested for SCD risk of sequences identified herein to correlate quantitatively with SCD risk. Both the number of such sequences present and their alignment scores (similarity) with the SCD risk sequence ensemble are used to calculate quantitative SCD risk.